For men with benign prostatic hyperplasia (BPH), urinary symptoms such as weak flow, frequent urination, urgency, or difficulty emptying the bladder can interfere with everyday life.
The iTind™ procedure is a minimally invasive treatment option for selected men with BPH. It uses a temporary nitinol device placed in the prostatic urethra. The device gradually reshapes the passage to improve urine flow and is removed after several days.
Studies have reported improvements in urinary symptoms and flow following iTind, while sexual and ejaculatory function was generally preserved in the available studies. However, iTind is not suitable for every prostate or every type of urinary obstruction, and longer-term comparative evidence is still developing.
Dr. Cheol-Young Yoon performs the iTind™ procedure.
As with any BPH treatment, the appropriate option depends on factors such as prostate anatomy, symptom severity, urinary function, medications, and individual treatment goals. A proper urological evaluation is therefore important before choosing a procedure.